Takeda’s Eohilia See
Takeda’s Eohilia Sees Strong Early Adoption and Growth Potential in Eosinophilic Esophagitis, According to Spherix Global Insights
July 18, 2024 10:05 ET | Spherix Global Insights
EXTON, PA, July 18, 2024 (GLOBE NEWSWIRE) -- In February of this year, Takeda’s Eohilia (budesonide oral suspension) received FDA approval as the first and only oral therapy for eosinophilic...
FluGen-logo-CMYK USE THIS ONE PNG.png
FluGen’s Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults Shows Superiority Over Flu Shot Alone
July 12, 2024 07:00 ET | FluGen, Inc.
Combining FluGen's M2SR nasal spray flu vaccine with Sanofi's Fluzone High Dose shot generates superior results in older adults versus the shot alone.
Final Logo-01.png
Antidiuretic Drugs Market Size & Share to Exceed USD 1504.8 Million by 2034, at CAGR of 11.5%. "Fluid Harmony: Navigating the Antidiuretic Drugs Market for Optimal Hydration Solutions" – PMI Leads the Way
February 01, 2024 15:00 ET | PMI
Covina, Feb. 01, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Antidiuretic Drugs Market size was valued at about USD 558.7 Million in 2024 and expected to grow at CAGR of...
IMF_logo_RGB.png
The International Myeloma Foundation is Creating an Award-Winning Tool for Nurses to Improve Myeloma Patient Outcomes in Underserved Communities
November 02, 2023 13:15 ET | International Myeloma Foundation
The International Myeloma Foundation wins the 2023 Sanofi HealthEquity Accelerator Award for their program which empowers nurses and tackles disparities.
First-Wave-Logo-FINAL-RGB[1].jpg
First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi
September 14, 2023 06:00 ET | First Wave BioPharma, Inc.
BOCA RATON, Fla., Sept. 14, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the...
Final Logo-01.png
[PDF] Leprosy Treatment Market is estimated to be US$ 4.09 billion by 2030 with a CAGR of 4.50% during the forecast period – By PMI
September 05, 2023 14:30 ET | PMI
Covina, Sept. 05, 2023 (GLOBE NEWSWIRE) -- According to the latest research study, the demand of “Leprosy Treatment Market accounted for US$ 2.65 billion in 2020 and is estimated to be US$ 4.09...
Mordor Intelligence Logo_Comp.png
North America Diabetes Care Devices Market Revenues to Reach USD 35.02 Billion by 2028 - Market Size, Share, Forecasts, & Trends Analysis Report by Mordor Intelligence
August 21, 2023 09:30 ET | Mordor Intelligence
Hyderabad, Aug. 21, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled "North America Diabetes Care Devices Market Report (2023-2028)," the market is estimated at USD 25.91...
An Old Dog with a Ne
An Old Dog with a New Trick… Ellodi’s APT-1011 Promises EoE Patients a Convenient and Potent Treatment Alternative
August 15, 2023 15:40 ET | Spherix Global Insights
Exton, Pennsylvania, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Since launching in May 2022, Sanofi/Regeneron’s Dupixent has been well received by gastroenterologists and allergists as an advancement for...
Mordor Intelligence Logo_Comp.png
Mexico Insulin Drugs and Delivery Devices Market Revenues to Reach USD 566.91 million by 2028 - Market Size, Share, Forecasts, & Trends Analysis Report by Mordor Intelligence
August 09, 2023 09:30 ET | Mordor Intelligence
Hyderabad, Aug. 09, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled "Mexico Insulin Drugs and Delivery Devices Market Report (2023-2028)," the market is estimated at USD...
Mordor Intelligence Logo_Comp.png
Preventive Vaccines Market Revenues to Reach USD 94.70 Billion by 2028 - Market Size, Share, Forecasts, & Trends Analysis Report by Mordor Intelligence
August 02, 2023 09:30 ET | Mordor Intelligence
Hyderbad, Aug. 02, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled "Preventive Vaccines Market Report (2023-2028)," the market is estimated at USD 88.26 billion in 2023. It...